Showing results (1191-1200 of 4,518) with videos related to
Sort By:
Pageof 452
Journal of Internal Medicine|March 2, 2022
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilastIvan Arias de la Rosa, Maria Dolores López-Montilla, Cristobal Román-Rodríguez, et al.Journal of Internal Medicine|December 7, 2023
Is shrunken pore syndrome also a reality in children?Mathilde Roussel, Justine Bacchetta, Anne Laure Sellier-Leclerc, et al.Journal of Internal Medicine|November 29, 2023
Vagus nerve SARS-CoV-2 infection and inflammatory reflex dysfunction: Is there a causal relationship?Ulf Andersson, Kevin J TraceyJournal of Internal Medicine|November 20, 2023
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survivalSimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.Journal of Internal Medicine|November 5, 2023
HbA1c-dependent projection of long-term renal outcomesFrederic Arnold, Julia Kappes, Felix A Rottmann, et al.Journal of Internal Medicine|October 29, 2023
Increased risk of dementia differs across cardiovascular diseases and types of dementia - Data from a nationwide studyAnni Kauko, Daniel Engler, Teemu Niiranen, et al.Journal of Internal Medicine|October 29, 2023
Does cardiovascular risk matter in IBD patients?Herbert Tilg, Mathurin Fumery, Charlotte R H HedinJournal of Internal Medicine|August 29, 2023
Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment-A nationwide register-based studyKatarina Glise Sandblad, Sam Schulman, Annika Rosengren, et al.Journal of Internal Medicine|August 4, 2023
The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW-CKDCheol Ho Park, Hyung Woo Kim, Jung Tak Park, et al.Journal of Internal Medicine|August 18, 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trialSophie Dupuis-Girod, Sophie Rivière, Christian Lavigne, et al.Pageof 452